135
Views
40
CrossRef citations to date
0
Altmetric
Original Research

Differences in systemic inflammation between cigarette and biomass smoke-induced COPD

, , , , , & show all
Pages 2639-2646 | Published online: 01 Sep 2017

References

  • SalviSBarnesPJIs exposure to biomass smoke the biggest risk factor for COPD globally?Chest20101383620605806
  • SoodAPetersenHBlanchetteCMWood smoke exposure and gene promoter methylation are associated with increased risk for COPD in smokersAm J Respir Crit Care Med201018291098110420595226
  • Orozco-LeviMGarcía-AymerichJVillarJRamírez-SarmientoAAntoJMGeaJWood smoke exposure and risk of chronic obstructive pulmonary diseaseEur Respir J200627354254616507854
  • López-CamposJLFernández-VillarACalero-AcuñaCOn-Sint Study InvestigatorsOccupational and biomass exposure in chronic obstructive pulmonary disease: results of a cross-sectional analysis of the On-Sint studyArch Bronconeumol20175371227432162
  • Ramírez-VenegasASansoresRHQuintana-CarrilloRHFEV1 decline in patients with chronic obstructive pulmonary disease associated with biomass exposureAm J Respir Crit Care Med20141909996100225172140
  • CampPGRamírez-VenegasASansoresRHCOPD phenotypes in biomass smoke- versus tobacco smoke-exposed Mexican womenEur Respir J201443372573424114962
  • MehraDGeraghtyPMHardiganAAForonjyRA comparison of the inflammatory and proteolytic effects of dung biomass and cigarette smoke exposure in the lungPLoS One2012712e5288923285217
  • Solleiro-VillavicencioHQuintana-CarrilloRFalfán-ValenciaRVargas-RojasMIChronic obstructive pulmonary disease induced by exposure to biomass smoke is associated with a Th2 cytokine production profileClin Immunol2015161215015526220216
  • GolpeRSanjuán-LópezPCano-JiménezECastro-AñónOPérez-de-LlanoLADistribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smokeArch Bronconeumol20145031832424576449
  • CelliBRLocantoreNYatesJECLIPSE InvestigatorsInflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2012185101065107222427534
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD) [homepage on the Internet]Global Strategy for the Diagnosis, Management and Prevention of COPD 2017 Available from: http://goldcopd.org/Accessed June 12, 2017
  • García-RíoFCalleMBurgosFNormativa SEPAR. EspirometríaArch Bronconeumol20134938840123726118
  • Pinto-PlataVMMüllerovaHTosoJFC-reactive protein in patients with COPD, control smokers and non-smokersThorax2006611232816143583
  • Vargas-RojasMISolleiro-VillavicencioHRamírez-VenegasAVelázquez-UncalMQuintanaRSansores-MartínezRDifferences in the polarization of the inflammatory response of patients with chronic obstructive pulmonary disease (COPD) secondary to smoking and to biomass smoke exposureEur Respir J201342Suppl 57595
  • FabbriLMRabeKFFrom COPD to chronic systemic inflammatory syndrome?Lancet200737079779917765529
  • MontañoMSansoresRHBecerrilCFEV1 inversely correlates with metalloproteinases 1, 7, 9 and CRP in COPD by biomass smoke exposureRespir Res2014157424980707
  • LiuYBerthier-SchaadYFallinMDIL-6 haplotypes, inflammation and risk for cardiovascular disease in a multiethnic dialysis cohortJ Am Soc Nephrol20061786387016467451
  • Van FleterenLESpruitMAGroenenMClusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2013187772873523392440
  • ApostolakisSVogiatziKAmanatidouVSpanidosDAInterleukin 8 and cardiovascular diseaseCardiovasc Res200984335336019617600
  • GolpeRMartín-RoblesISanjuán-LópezPPrevalence of major comorbidities in chronic obstructive pulmonary disease caused by biomass smoke or tobaccoRespiration2017941384428456807
  • GrumelliSCorryDBSongLZAn immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysemaPLoS Med200411e815526056
  • HolgateSTInnate and adaptive immune responses in asthmaNat Med201218567368322561831
  • Vargas-RojasMIRamírez-VenegasALimón-CamachoLOchoaLHernández-ZentenoRSansoresRHIncrease of Th17 cells in peripheral blood of patients with chronic obstructive pulmonary diseaseRespir Med2011105111648165421763119
  • Di StefanoACaramoriGGnemmiIT helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patientsClin Exp Immunol2009157231632419604272
  • De TorresJPCasanovaCHernándezCAbreuJAguirre-JaimeACelliBRGender and COPD in patients attending a pulmonary clinicChest200512842012201616236849
  • HongYJiWAnSHanSSLeeSJKimWJSex differences of COPD phenotypes in nonsmoking patientsInt J Chron Obstruct Pulmon Dis2016111657166227524891
  • FanerRGonzálezNCruzTGraciela-KalkoSAgustíASystemic inflammatory response to smoking in chronic obstructive pulmonary disease: evidence of a gender effectPLoS One201495e9749124830457
  • SussanTEIngoleVKimJHSource of biomass cooking fuel determines pulmonary response to household air pollutionAm J Respir Cell Mol Biol201450353854824102120
  • KhuranaSRaviASutulaJClinical characteristics and airway inflammation profile of COPD persistent sputum producersRespir Med2014108121761177025459449
  • RöpckeSHolzOLauerGRepeatability of and relationship between potential COPD biomarkers in bronchoalveolar lavage, bronchial biopsies, serum and induced sputumPLoS One2012710e4620723056262
  • NúñezBSauledaJGarcia-AymerichJMiembros del Grupo de Trabajo sobre la Caracterización Fenotípica y Evolución de la EPOC (PAC-COPD). Lack of correlation between pulmonary and systemic inflammation markers in patients with chronic obstructive pulmonary disease: a simultaneous, two-compartmental analysisArch Bronconeumol20165236136726921918
  • AkikiZFakihDJounblatRSurfactant protein D, a clinical biomarker for chronic obstructive pulmonary disease with excellent discriminant valuesExp Ther Med201611372373026997985
  • AgustíAEdwardsLDRennardSIEvaluation of COPD longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) InvestigatorsPersistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotypePLoS One201275e3748322624038
  • EisnerMDAnthonisenNCoultasDon behalf of the Environmental and Occupational Health Assembly Committee on Nonsmoking COPDAn official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2010182569371820802169